Engineering the Microbiome: a Novel Approach to Immunotherapy for Allergic and Immune Diseases

[1]  J. Clemente,et al.  Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome? , 2015, Expert review of gastroenterology & hepatology.

[2]  Rob Knight,et al.  The microbiome of uncontacted Amerindians , 2015, Science Advances.

[3]  R. Pieters,et al.  DHA-rich tuna oil effectively suppresses allergic symptoms in mice allergic to whey or peanut. , 2014, The Journal of nutrition.

[4]  G. Russell,et al.  Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. , 2014, JAMA.

[5]  Joann H. Lin.  Normocaloric Diet Improves Asthma-Related Quality of Life in Obese Pubertal Adolescents , 2014, Pediatrics.

[6]  A. Gasbarrini,et al.  Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement , 2014, Medicine.

[7]  James J Collins,et al.  Antibiotics and the gut microbiota. , 2014, The Journal of clinical investigation.

[8]  B. Gold,et al.  Clinical and Mucosal Improvement With Specific Carbohydrate Diet in Pediatric Crohn Disease , 2014, Journal of pediatric gastroenterology and nutrition.

[9]  V. Flamand,et al.  Unbalanced Neonatal CD4+ T-Cell Immunity , 2014, Front. Immunol..

[10]  M. Blaser,et al.  Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences , 2014, Cell.

[11]  C. Mackay,et al.  Diet, metabolites, and "western-lifestyle" inflammatory diseases. , 2014, Immunity.

[12]  R. Russell,et al.  Decline in Presumptively Protective Gut Bacterial Species and Metabolites Are Paradoxically Associated with Disease Improvement in Pediatric Crohn’s Disease During Enteral Nutrition , 2014, Inflammatory bowel diseases.

[13]  A. Khoruts,et al.  Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation , 2014, Microbiome.

[14]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[15]  M. Tomita,et al.  Erratum: Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2014, Nature.

[16]  T. Junt,et al.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis , 2014, Nature Medicine.

[17]  D. Suskind,et al.  Nutritional Therapy in Pediatric Crohn Disease: The Specific Carbohydrate Diet , 2014, Journal of pediatric gastroenterology and nutrition.

[18]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[19]  L. Boon,et al.  CD25+ regulatory T cells transfer n‐3 long chain polyunsaturated fatty acids‐induced tolerance in mice allergic to cow's milk protein , 2013, Allergy.

[20]  R. Gearry,et al.  Use of exclusive enteral nutrition in adults with Crohn's disease: a review. , 2013, World journal of gastroenterology.

[21]  Rob Knight,et al.  A Modular Organization of the Human Intestinal Mucosal Microbiota and Its Association with Inflammatory Bowel Disease , 2013, PloS one.

[22]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[23]  Max Nieuwdorp,et al.  Therapeutic potential of fecal microbiota transplantation. , 2013, Gastroenterology.

[24]  Jan Verhaegen,et al.  A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis , 2013, Gut.

[25]  Julie Wang.  Treatment of food anaphylaxis with traditional Chinese herbal remedies: from mouse model to human clinical trials , 2013, Current opinion in allergy and clinical immunology.

[26]  J. Clemente,et al.  The Long-Term Stability of the Human Gut Microbiota , 2013 .

[27]  J. Garssen,et al.  Dietary long chain n‐3 polyunsaturated fatty acids prevent allergic sensitization to cow's milk protein in mice , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  A. Day,et al.  Exclusive enteral nutrition and induction of remission of active Crohn’s disease in children , 2013, Expert review of clinical immunology.

[29]  D. Sinderen,et al.  Selective carbohydrate utilization by lactobacilli and bifidobacteria , 2013, Journal of applied microbiology.

[30]  Sebastian Tims,et al.  Long-term monitoring of the human intestinal microbiota composition. , 2013, Environmental microbiology.

[31]  Sanjoy Ghosh,et al.  Fish Oil Attenuates Omega-6 Polyunsaturated Fatty Acid-Induced Dysbiosis and Infectious Colitis but Impairs LPS Dephosphorylation Activity Causing Sepsis , 2013, PloS one.

[32]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[33]  K. Magnusson,et al.  Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease , 2012, Scandinavian journal of gastroenterology.

[34]  Samuel I. Miller,et al.  The Microbiome and Inflammatory Bowel Disease: Is There a Therapeutic Role for Fecal Microbiota Transplantation? , 2012, The American Journal of Gastroenterology.

[35]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[36]  M. Li,et al.  Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats , 2012, PloS one.

[37]  M. Hattori,et al.  Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters , 2012, Gut microbes.

[38]  M. Severgnini,et al.  Diversity of Bifidobacteria within the Infant Gut Microbiota , 2012, PloS one.

[39]  E. Martens,et al.  How glycan metabolism shapes the human gut microbiota , 2012, Nature Reviews Microbiology.

[40]  Yunwei Wang,et al.  Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice , 2012, Nature.

[41]  J. Clemente,et al.  Human gut microbiome viewed across age and geography , 2012, Nature.

[42]  V. Anttila,et al.  Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. , 2012, Gastroenterology.

[43]  P. Gionchetti,et al.  Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. , 2012, Gastroenterology.

[44]  E. Hobeika,et al.  Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles , 2011, Science.

[45]  J. Bakken,et al.  Treating Clostridium difficile infection with fecal microbiota transplantation. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[46]  A. Manges,et al.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  Natalie A. Roberts,et al.  Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation , 2011, Cell.

[48]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[49]  L. Boon,et al.  Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  W. D. de Vos,et al.  Intestinal Microbiota in Healthy Adults: Temporal Analysis Reveals Individual and Common Core and Relation to Intestinal Symptoms , 2011, PloS one.

[51]  J. Bluestone,et al.  Control of TH17 cells occurs in the Small Intestine , 2011, Nature.

[52]  J. Clemente,et al.  Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.

[53]  D. Artis,et al.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 , 2011, Nature Immunology.

[54]  D. Bruce,et al.  Intrinsic Requirement for the Vitamin D Receptor in the Development of CD8αα-Expressing T Cells , 2011, The Journal of Immunology.

[55]  J. Parkhill,et al.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.

[56]  H. Sampson,et al.  Bioactivities of Berberine, Palmatine, and Jatrorrhizine isolated from Food Allergy Herbal Formula 2 (FAHF-2) , 2011 .

[57]  M. Hattori,et al.  Bifidobacteria can protect from enteropathogenic infection through production of acetate , 2011, Nature.

[58]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[59]  J. Garssen,et al.  Early life: gut microbiota and immune development in infancy. , 2010, Beneficial microbes.

[60]  Jacqueline D Wright,et al.  Trends in intake of energy and macronutrients in adults from 1999-2000 through 2007-2008. , 2010, NCHS data brief.

[61]  Y. Sanz,et al.  Intestinal Bacteroides species associated with coeliac disease , 2010, Journal of Clinical Pathology.

[62]  V. Verhasselt.  Neonatal tolerance under breastfeeding influence. , 2010, Current opinion in immunology.

[63]  F. Clavel-Chapelon,et al.  Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study , 2010, The American Journal of Gastroenterology.

[64]  Jae-Hoon Chang,et al.  1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of TH17 Cells to Protect against Experimental Autoimmune Encephalomyelitis , 2010, PloS one.

[65]  J. Rutledge,et al.  Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[66]  H. Tajiri,et al.  What's Hot in the Red Journal This Month? , 2010, The American Journal of Gastroenterology.

[67]  J. Godbold,et al.  US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. , 2010, The Journal of allergy and clinical immunology.

[68]  G. Michel,et al.  Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota , 2010, Nature.

[69]  H. Kiyono,et al.  Aberrant Interaction of the Gut Immune System with Environmental Factors in the Development of Food Allergies , 2010, Current allergy and asthma reports.

[70]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[71]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[72]  Harry J Flint,et al.  The role of pH in determining the species composition of the human colonic microbiota. , 2009, Environmental microbiology.

[73]  R. Mullins,et al.  Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. , 2009, The Journal of allergy and clinical immunology.

[74]  I. Adlerberth,et al.  Establishment of the gut microbiota in Western infants , 2009, Acta paediatrica.

[75]  Y. Sanz,et al.  Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease , 2008, BMC Microbiology.

[76]  Y. Sanz,et al.  Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease , 2008, Journal of Clinical Pathology.

[77]  Les Dethlefsen,et al.  The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.

[78]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[79]  M. Spehlmann,et al.  Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study , 2008, Inflammatory bowel diseases.

[80]  D. Artis.  Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.

[81]  A. Ellis,et al.  Clinical trial: randomized study of clarithromycin versus placebo in active Crohn’s disease , 2008, Alimentary pharmacology & therapeutics.

[82]  H. Feder.  Lyme disease in children. , 2008, Infectious disease clinics of North America.

[83]  J. Penders,et al.  The role of the intestinal microbiota in the development of atopic disorders , 2007, Allergy.

[84]  Wendy S. Garrett,et al.  Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.

[85]  Y. Belkaid,et al.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.

[86]  Hilde Cheroutre,et al.  Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.

[87]  W. Selby,et al.  Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.

[88]  S. Fisher,et al.  A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. , 2007, Gastroenterology.

[89]  A. Ouwehand.  Antiallergic effects of probiotics. , 2007, The Journal of nutrition.

[90]  M. Ege,et al.  The asthma epidemic. , 2006, The New England journal of medicine.

[91]  P. Ricciardi-Castagnoli,et al.  Generation of Gut-Homing IgA-Secreting B Cells by Intestinal Dendritic Cells , 2006, Science.

[92]  A. Day,et al.  Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: A feasible and effective approach , 2006, Journal of gastroenterology and hepatology.

[93]  R. Sartor.  Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[94]  M. Makrides,et al.  Diet of lactating women and allergic reactions in their infants , 2006, Current opinion in clinical nutrition and metabolic care.

[95]  G. Huffnagle,et al.  The ‘microflora hypothesis’ of allergic diseases , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[96]  C. Hill,et al.  The interaction between bacteria and bile. , 2005, FEMS microbiology reviews.

[97]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[98]  R. Sartor,et al.  Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. , 2005, Gastroenterology.

[99]  T. Haahtela,et al.  Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double‐blind placebo‐controlled trial , 2005, Allergy.

[100]  Si-young Song,et al.  Retinoic acid imprints gut-homing specificity on T cells. , 2004, Immunity.

[101]  M. Pearce,et al.  Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study , 2004, Gut.

[102]  R. Korpela,et al.  Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. , 2004, The Journal of allergy and clinical immunology.

[103]  M. Grigorov,et al.  Soluble Forms of Toll-Like Receptor (TLR)2 Capable of Modulating TLR2 Signaling Are Present in Human Plasma and Breast Milk , 2003, The Journal of Immunology.

[104]  E. Lindberg,et al.  Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. , 2003, Gastroenterology.

[105]  T. Ohkusa,et al.  Antibiotic combination therapy in patients with chronic ulcerative colitis , 2003 .

[106]  Belinda Bateman,et al.  Rising prevalence of allergy to peanut in children: Data from 2 sequential cohorts. , 2002, The Journal of allergy and clinical immunology.

[107]  T. Warner,et al.  Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. , 2002, The American journal of pathology.

[108]  H. Chung,et al.  Molecular exploration of age-related NF-kappaB/IKK downregulation by calorie restriction in rat kidney. , 2002, Free radical biology & medicine.

[109]  K. Petraki,et al.  A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. , 2001, Scandinavian journal of gastroenterology.

[110]  E. Schiffrin,et al.  Induction by a Lactic Acid Bacterium of a Population of CD4+ T Cells with Low Proliferative Capacity That Produce Transforming Growth Factor β and Interleukin-10 , 2001, Clinical Diagnostic Laboratory Immunology.

[111]  A. Cohen,et al.  Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. , 2001, Gastroenterology.

[112]  A. Baird,et al.  Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. , 2000, Journal of pediatric gastroenterology and nutrition.

[113]  M. Affolter,et al.  Innate Recognition of Bacteria in Human Milk Is Mediated by a Milk-Derived Highly Expressed Pattern Recognition Receptor, Soluble Cd14 , 2000, The Journal of experimental medicine.

[114]  G. Gibson,et al.  Healthy gut microflora and allergy: factors influencing development of the microbiota. , 1999, Annals of medicine.

[115]  J. Fallingborg,et al.  Intraluminal pH of the human gastrointestinal tract. , 1999, Danish medical bulletin.

[116]  P. Brigidi,et al.  Antibiotic combination therapy in patients with chronic, treatment‐resistant pouchitis , 1999, Alimentary pharmacology & therapeutics.

[117]  W. Sandborn.  Severe ulcerative colitis , 1999, Current treatment options in gastroenterology.

[118]  J. Mary,et al.  A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease , 1999, American Journal of Gastroenterology.

[119]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[120]  J M Ward,et al.  Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.

[121]  M. Färkkilä,et al.  Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. , 1998, Gastroenterology.

[122]  Chyung-Ru Wang,et al.  Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.

[123]  K. Petraki,et al.  A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. , 1997, The American journal of gastroenterology.

[124]  R. Sartor.  Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. , 1995, Gastroenterology clinics of North America.

[125]  S. Hanauer,et al.  Double blind, placebo controlled trial of metronidazole in Crohn's disease. , 1991, Gut.

[126]  J. Crowe,et al.  Controlled trial of antimycobacterial therapy in Crohn's disease , 1991, Digestive diseases and sciences.

[127]  A. Axon,et al.  Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. , 1985, Gut.

[128]  James Carmichael.  Disease in Children , 1893, Bristol Medico-Chirurgical Journal (1883).

[129]  G. Gerber,et al.  A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. , 2013, The Journal of allergy and clinical immunology.

[130]  L. Mayer,et al.  Can we produce true tolerance in patients with food allergy? , 2013, The Journal of allergy and clinical immunology.

[131]  K. Zimmermann,et al.  A vegan or vegetarian diet substantially alters the human colonic faecal microbiota , 2012, European Journal of Clinical Nutrition.

[132]  Yunwei Wang,et al.  Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il 10 2 / 2 mice , 2012 .

[133]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[134]  C. Filippo.  Impact of diet in shaping gut microbiota , 2012 .

[135]  박주홍,et al.  The Toll-Like Receptor 2 pathway Establishes Colonization by a Commensal of the Human Microbiota , 2011 .

[136]  H. Lee,et al.  Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation. , 2011, Molecular immunology.

[137]  J. Neu,et al.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns , 2011 .

[138]  Jae-Hoon Chang,et al.  1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis , 2010 .

[139]  J. Stockman.  Breast milk–mediated transfer of an antigen induces tolerance and protection from allergic asthma , 2009 .

[140]  H. Sampson,et al.  Food allergy: recent advances in pathophysiology and treatment. , 2009, Annual review of medicine.

[141]  E. Zoetendal,et al.  Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. , 2007, Research in microbiology.

[142]  Luying Peng,et al.  Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier , 2007, Pediatric Research.

[143]  D. N. H. A. Mrcpi,et al.  Controlled trial of antimycobacterial therapy in Crohn's disease , 2005, Digestive Diseases and Sciences.

[144]  J. Le Pendu.  Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. , 2004, Advances in experimental medicine and biology.

[145]  Jacques Le Pendu,et al.  Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. , 2004 .

[146]  T. Sørensen,et al.  Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. , 2000, Scandinavian journal of gastroenterology.

[147]  J. Lipman,et al.  Antibiotics and the gut , 1996 .

[148]  G. Mantzaris,et al.  Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. , 1994, The American journal of gastroenterology.

[149]  P. Blichfeldt,et al.  Metronidazole in Crohn's disease. A double blind cross-over clinical trial. , 1978, Scandinavian journal of gastroenterology.

[150]  J. Nasio.  [Severe ulcerative colitis or polycausal ulcerative colitis]. , 1955, Revista clinica espanola.